Recombinant Human Angiotensin-converting Enzyme 2 (rhACE2) as a Treatment for Patients With COVID-19
Clinical trial NCT04287686 · WITHDRAWN
Trial details
- NCT number
- NCT04287686
- Sponsor
- The First Affiliated Hospital of Guangzhou Medical University
- Status
- WITHDRAWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-01
- Primary completion
- 2020-04-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.